According to the results of systemic analysis, high PANDAR expression was related to reduced OS in colorectal cancer (HR 3.43; 95% CI 2.06–5.72, p < 0.001) (Figure 5A) and low expression level of PANDAR was significantly associated with poor OS in non-small cell lung cancer (pooled HR 0.65, 95%CI 0.45–0.88, p = 0.006) (Figure 5B). The gene discussed is PANDAR; the disease is non-small cell lung carcinoma.